WP-RT3
From $62.99 / vial
For in-vitro laboratory research use only. Not for human or veterinary use.
Reference compound: Retatrutide · CAS 2381089-83-2. Lyophilized powder, 10 mg, 20 mg. Single vial, Buy-2-Get-1 3-pack, or 10-vial lab kit. For in-vitro laboratory research use only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. Sold to qualified researchers aged 21+.
For in-vitro laboratory research use only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. Sold to qualified researchers aged 21+.
What WP-RT3 is
Retatrutide (LY3437943) is a synthetic 39-amino-acid peptide engineered as a single-molecule agonist of three receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor and the glucagon receptor. A C20 fatty-diacid side chain promotes albumin binding and extends the half-life in the research literature.
Mechanism described in the literature
In receptor-pharmacology studies, retatrutide shows balanced activity at GIPR and GLP-1R with lower, but functionally relevant, potency at the glucagon receptor. The three pathways are studied together because they converge on cyclic-AMP signaling in pancreatic islets, the hypothalamus and the liver, with glucagon-receptor activity of interest for its role in hepatic energy expenditure and lipid turnover.
Research areas
- Incretin and glucagon receptor signaling
- Energy balance and adiposity models
- Glucose homeostasis and islet biology
- Hepatic steatosis (MASLD) models
- Comparative pharmacology of mono-, dual- and tri-agonists
Specifications
| Product code | WP-RT3 |
|---|---|
| Reference compound | Retatrutide |
| CAS number | 2381089-83-2 |
| Molecular formula | C221H342N46O68 |
| Molecular weight | 4731.3 g/mol |
| Composition | 39-amino-acid peptide with a C20 fatty-diacid side chain; acetate salt |
| Form | Lyophilized powder |
| Net content options | 10 mg, 20 mg |
| Container | 3 mL clear glass vial, crimped aluminum seal, flip-off cap |
| Storage | Store sealed vials at -20 °C, protected from light and moisture. 2–8 °C is acceptable for short periods such as transit and receiving. Allow a cold vial to reach room temperature before opening to avoid condensation on the lyophilized cake. |
| Intended use | In-vitro laboratory research only |
Sizes and packs
Single vial at list price · 3-Pack = Buy 2, Get 1 Free (exactly 2× list) · 10-Vial Lab Kit = 25% off list. Select the size and pack above; the price updates.
Handling and storage
Store sealed vials at -20 °C, protected from light and moisture. 2–8 °C is acceptable for short periods such as transit and receiving. Allow a cold vial to reach room temperature before opening to avoid condensation on the lyophilized cake.
Vials ship sealed, cushioned and with a desiccant pack in plain packaging. Each vial is labeled with the product code, net content and the research-use designation. A packing slip lists the product codes and quantities ordered.
Frequently asked questions
Who can order?
Qualified researchers aged 21+ purchasing for in-vitro laboratory research. You confirm this at site entry and again at checkout.
When does it ship?
Orders confirmed by 2 PM CT ship the same business day by USPS Priority Mail (1–3 business days). Free shipping on orders over $149. Tracking is emailed when the carrier scans the label.
Can I return it?
All sales are final. Items that arrive damaged or incorrect are replaced when reported with photos within 72 hours of delivery — see Shipping & Returns.
References
- Coskun T, Urva S, Roell WC, et al.. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept. Cell Metabolism 2022. doi:10.1016/j.cmet.2022.07.013
- Jastreboff AM, Kaplan LM, Frías JP, et al.. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. New England Journal of Medicine 2023. doi:10.1056/NEJMoa2301972
- Sanyal AJ, Kaplan LM, Frias JP, et al.. Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. Nature Medicine 2024. doi:10.1038/s41591-024-03018-2
This overview summarizes published literature about the reference compound and is provided for research context only. It is not a description of the properties, effects or uses of this product, which is supplied strictly for in-vitro laboratory research by qualified researchers. Nothing on this page is an instruction for preparation or use.
For in-vitro laboratory research use only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. Sold to qualified researchers aged 21+.
Available sizes and packs
| Weight | N/A |
|---|---|
| Size | 10 mg, 20 mg |
| Pack | Single vial, 3-Pack · Buy 2 Get 1 Free, 10-Vial Lab Kit |







